¼¼°èÀÇ ¹ÙÀÌ¿À ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ÃÖÁ¾»ç¿ëÀÚº°, À¯Çüº°, Áö¿ªº°, Àü¸Á ¹× ¿¹Ãø(2024-2031³â)
Global Bioimplants Market Size, Share & Trends Analysis Report By End User, By Type, By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1529196
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 215 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 4,988,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 5,986,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,381,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¹ÙÀÌ¿À ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 8.0%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 2,392¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª ¿¬±¸°³¹ß¿¡ ÇÊ¿äÇÑ ¸·´ëÇÑ ÅõÀÚ·Î ÀÎÇØ °æÁ¦Àû ºÎ´ãÀÌ ½ÃÀ۵˴ϴÙ. ÀÌ·¯ÇÑ ÀÓÇöõÆ®ÀÇ Á¦Á¶ °øÁ¤µµ ³ôÀº °¡°ÝÀÇ ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ÀÇ·á±â±âÀÇ Á¦Á¶¿¡´Â ÀϹÝÀûÀ¸·Î °í±Þ ¹× °í°¡ÀÇ Àç·á°¡ »ç¿ëµË´Ï´Ù. µû¶ó¼­ °³¹ß, Á¦Á¶ ¹× ±¸Çö°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ±¤¹üÀ§ÇÑ µµÀÔ¿¡ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¶Ç ÇÑ °¡Áö ÁÖ¸ñÇÒ ¸¸ÇÑ ±àÁ¤ÀûÀÎ ¿µÇâ Áß Çϳª´Â ¿ø°ÝÀÇ·á¿Í µðÁöÅÐ °Ç°­ ±â¼úÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ¾ú´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ÀÓÇöõÆ®°¡ ÇÊ¿äÇÑ È¯ÀÚ¸¦ Æ÷ÇÔÇÏ¿© ¸¸¼º ÁúȯÀ» ¾Î°í Àִ ȯÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí ÃßÀû °üÂûÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ´ë¸é Áø·á°¡ Á¦Çѵʿ¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚ Ä¡·á¸¦ À¯ÁöÇϱâ À§ÇØ ¿ø°ÝÀÇ·á Ç÷§Æû¿¡ Á¡Á¡ ´õ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ Àü¿°º´Àº Àü¹ÝÀûÀ¸·Î ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚ Àü¸Á

ÃÖÁ¾»ç¿ëÀÚ¸¦ ±âÁØÀ¸·Î ½ÃÀåÀº º´¿ø, Àü¹® Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ·Î ºÐ·ùµË´Ï´Ù. Àü¹® Ŭ¸®´Ð ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 32%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù. Àü¹® Ŭ¸®´ÐÀº ½ÉÀåÇÐ, Á¤Çü¿Ü°ú, Ä¡°ú, ¾È°ú µî ƯÁ¤ ÀÇ·á ºÐ¾ß¸¦ Àü¹®À¸·ÎÇÏ¸ç Æ¯Á¤ °Ç°­ »óŸ¦ °¡Áø ȯÀÚ¿¡°Ô °íµµ·Î Àü¹®ÀûÀÎ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù.

À¯Çüº° Àü¸Á

À¯Çü¿¡ µû¶ó ½ÃÀåÀº Ä¡°ú¿ë ¹ÙÀÌ¿À ÀÓÇöõÆ®, Á¤Çü¿Ü°ú¿ë ¹ÙÀÌ¿À ÀÓÇöõÆ®, ôÃß ¹ÙÀÌ¿À ÀÓÇöõÆ®, ¾È°ú¿ë ¹ÙÀÌ¿À ÀÓÇöõÆ®, ½ÉÇ÷°ü ¹ÙÀÌ¿À ÀÓÇöõÆ®, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ½ÉÇ÷°ü ¹ÙÀÌ¿À ÀÓÇöõÆ® ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 20%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ(CVD)Àº Àü ¼¼°èÀûÀ¸·Î ÀÌȯÀ²°ú »ç¸Á·üÀÇ °¡Àå ÈçÇÑ ¿øÀÎ Áß ÇϳªÀ̱⠶§¹®¿¡ È¿°úÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Ä¡·á ¿É¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î º¸¸é ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, LAMEA¿¡ °ÉÃÄ ºÐ¼®µÇ¾ú½À´Ï´Ù. ºÏ¹Ì ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 36%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¸®´õ½ÊÀº ÁÖ·Î ÀÌ Áö¿ªÀÇ Ã·´Ü ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ÀÇ·á ºñ¿ë, Àú¸íÇÑ ¹ÙÀÌ¿À ÀÓÇöõÆ® Á¦Á¶¾÷üÀÇ Á¸Àç¿¡ ±âÀÎÇÕ´Ï´Ù. ƯÈ÷ ¹Ì±¹Àº °­·ÂÇÑ ÀÇ·á ¿¬±¸ »ýŰè, ÷´Ü ÀÇ·á ±â¼úÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃ, À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾îÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¹ÙÀÌ¿À ÀÓÇöõÆ® ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦5Àå ¹ÙÀÌ¿À ÀÓÇöõÆ® ¼¼°è ½ÃÀå : À¯Çüº°

Á¦6Àå ¹ÙÀÌ¿À ÀÓÇöõÆ® ¼¼°è ½ÃÀå : Áö¿ªº°

Á¦7Àå ±â¾÷ °³¿ä

Á¦8Àå ¹ÙÀÌ¿À ÀÓÇöõÆ® ½ÃÀå ¼º°ø Çʼö Á¶°Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Bioimplants Market size is expected to reach $239.2 billion by 2031, rising at a market growth of 8.0% CAGR during the forecast period.

Europe is known for its comprehensive healthcare systems, high standards of medical care, and strong emphasis on medical research and innovation. Countries like Germany, France, the United Kingdom, and Italy are key contributors to the market in Europe, driven by their advanced healthcare facilities and growing geriatric population. Consequently, the European region would acquire nearly 30% of the total market share by 2031.

Innovations in biotechnology, materials science, and medical engineering have led to the development of more effective, durable, and biocompatible implants, which have been instrumental in boosting their adoption. Materials science has been equally instrumental in developing new and improved bioimplant materials. Hence, these developments will aid in the growth of the market. Additionally, Worldwide, the prevalence of chronic conditions, including cardiovascular diseases, orthopedic disorders, and dental issues, has resulted in the necessity of these implants for the effective treatment and management of these conditions. Dental problems are another significant contributor to the increasing demand for these implants. Millions of individuals worldwide are affected by tooth loss, periodontal disease, and other dental conditions, necessitating the development of effective restorative solutions. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, orthopedic disorders, and dental problems is a key factor driving the demand for these implants.

However, the financial burden begins with the substantial investment required for research and development. The manufacturing processes for these implants further contribute to their high price. Producing these advanced medical devices typically involves using sophisticated and expensive materials. Hence, the high costs associated with their development, production, and implementation remain a significant barrier to widespread adoption.

Moreover, one of the notable positive impacts was the accelerated adoption of telemedicine and digital health technologies. This shift enabled continuous monitoring and follow-up for patients with chronic conditions, including those requiring these implants. With restrictions on in-person consultations, healthcare providers increasingly turned to telehealth platforms to maintain patient care. Thus, the pandemic had an overall negative impact on the market.

End User Outlook

On the basis of end user, the market is classified into hospitals, speciality clinics, and ambulatory surgical centers. The specialty clinics segment witnessed 32% revenue share in the market in 2023. Specialist clinics concentrate on particular medical disciplines, including cardiology, orthopedics, dentistry, and ophthalmology, providing patients with particular medical conditions with highly specialized care.

Type Outlook

Based on type, the market is divided into dental bioimplants, orthopedic bioimplants, spinal bioimplants, ophthalmology bioimplants, cardiovascular bioimplants, and others. The cardiovascular bioimplants segment procured 20% revenue share in the market in 2023. Effective and dependable treatment options are required due to the fact that cardiovascular diseases (CVDs) continue to be one of the most prevalent causes of morbidity and mortality on a global scale.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 36% revenue share in the market in 2023. This leadership is primarily due to the region's sophisticated healthcare infrastructure, high healthcare expenditure, and the presence of prominent bioimplant manufacturers. The United States, in particular, is a key player in the market, as it has a robust medical research ecosystem, extensive adoption of sophisticated medical technologies, and favorable reimbursement policies.

List of Key Companies Profiled

Global Bioimplants Market Report Segmentation

By End User

By Type

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Bioimplants Market by End User

Chapter 5. Global Bioimplants Market by Type

Chapter 6. Global Bioimplants Market by Region

Chapter 7. Company Profiles

Chapter 8. Winning Imperatives of Bioimplants Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â